Dapagliflozin: a Sodium-glucose Cotransporter 2 Inhibitor, Attenuates Angiotensin II-induced Cardiac Fibrotic Remodeling by Regulating TGFβ1/ Smad Signaling
Yuze Zhang(Fujian Medical University), Dajun Chai(Fujian Medical University)
Cited by 0
Related Papers
Dapagliflozin: a sodium–glucose cotransporter 2 inhibitor, attenuates angiotensin II-induced cardiac fibrotic remodeling by regulating TGFβ1/Smad signaling
|Cardiovascular Diabetology|2021|98
Activation of AHR by ITE Improves Cardiac Remodelling and Function in Rats After Myocardial Infarction
|ESC Heart Failure|2023|36
Honokiol ameliorates angiotensin <scp>II</scp>‐induced cardiac hypertrophy by promoting dissociation of the <scp>Nur77–LKB1</scp> complex and activating the <scp>AMPK</scp> pathway
|Journal of Cellular and Molecular Medicine|2023|7